National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Cancer and the Environment
< Back to Main
    Posted: 04/07/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 30 : Hormones previousnext

Estrogen and progesterone are naturally occurring hormones. Given to women to treat the symptoms of menopause, they have been linked to increased risk of breast cancer.

Estrogen may also increase the risk of endometrial cancer, but progesterone helps protect against this increased risk. Estrogen and progestin (a synthetic form of progesterone) taken together are associated with increased risks of breast cancer, heart disease, stroke, and blood clots. Women who take oral contraceptives, which contain both estrogen and progesterone, may have increases in early-onset breast cancers and liver cancer, but have substantially reduced risks of endometrial and ovarian cancers.

Hormones

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov